Phthalazine derivatives as PARP inhibitors

Details for Australian Patent Application No. 2005259189 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Kennis, Ludo Edmond Josephine; Van Dun, Jacobus Alphonsus Josephus; Wouters, Walter Boudewijn Leopold; Mertens, Josephus Carolus; Mevellec, Laurence Anne; Somers, Maria Victorina Francisca

Agent Shelston IP

Pub. Number AU-B-2005259189

PCT Pub. Number WO2006/003147

Priority 04076886.3 30.06.04 EP

Filing date 28 June 2005

Wipo publication date 12 January 2006

Acceptance publication date 21 April 2011

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/502 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/003147 Priority application(s): WO2006/003147

21 April 2011 Application Accepted

  Published as AU-B-2005259189

18 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005259190-Quinazolinedione derivatives as PARP inhibitors

2005259188-Quinazolinone derivatives as PARP inhibitors